Gastroenterology 156 , 14161427 (2019)
GLP-1 medications are not officially FDA-approved for the treatment of PCOS, but theyre sometimes used off-label for PCOS, because of their effect on insulin resistance
Many patients benefit from weekly injections, while others may require bi-weekly or monthly treatments
The Medicare GLP-1 Bridge Program is a temporary coverage pathway that allows Part D plans to cover FDA-approved anti-obesity medications at a fixed copay of $50 per month
A report from the EMAs PRAC, published on 12 April 2024, said: After reviewing the available evidence from non-clinical studies, clinical trials, post-marketing surveillance data and the available studies the PRAC considers that no update to the product information is warranted. The PRAC statement said that market authorisation holders would continue to monitor events, including new studies, as part of their pharmacovigilance activities
Normotensive subjects experienced no clinically significant change in blood pressures (+1/2 mmHg)